T36	Exp 257 261	when
T37	Exp 174 184	the nuclei
T38	Exp 277 296	the kappa B element
T39	Exp 302 353	the interleukin-2 receptor-alpha (IL-2R alpha) gene
T40	Exp 453 457	each
T41	Exp 501 527	the v-rel oncogene product
T42	Exp 355 386	These two DNA-protein complexes
T43	Exp 551 565	these proteins
T44	Exp 738 742	that
T45	Exp 743 751	the more
T46	Exp 813 821	the more
T47	Exp 989 993	that
T48	Exp 918 960	the wild-type IL-2R alpha kappa B enhancer
T49	Exp 994 1005	the binding
T50	Exp 1077 1091	the 5' triplet
T51	Exp 1146 1160	the B1 complex
T52	Exp 1173 1184	the binding
T53	Exp 1225 1246	the more 3' sequences
T54	Exp 1250 1271	this enhancer element
T55	Exp 1416 1420	that
T56	Exp 1421 1425	both
T57	Exp 1481 1500	the kappa B element
T58	Exp 1300 1325	these Rel-related factors
T59	Exp 1429 1452	these basic amino acids
T60	Exp 1832 1836	that
T61	Exp 1887 1911	the DNA binding activity
T62	Exp 1809 1823	These findings
T63	Exp 1915 1926	this family
T64	SPAN 432 450	p50, p55, p75, p85
R9	Coref Anaphora:T43 Antecedent:T64
T65	SPAN 1188 1199	p75 and p85
R10	Coref Anaphora:T58 Antecedent:T65
T66	SPAN 1188 1199	p75 and p85
R11	Coref Anaphora:T56 Antecedent:T66
T1	Protein 306 334	interleukin-2 receptor-alpha
T2	Protein 336 347	IL-2R alpha
T3	Protein 432 435	p50
T4	Protein 437 440	p55
T5	Protein 442 445	p75
T6	Protein 447 450	p85
T7	Protein 505 510	v-rel
T8	Protein 658 661	p55
T9	Protein 662 665	p75
T10	Protein 676 679	p50
T11	Protein 680 683	p85
T12	Protein 795 798	p50
T13	Protein 803 806	p55
T14	Protein 865 868	p50
T15	Protein 870 873	p55
T16	Protein 875 878	p75
T17	Protein 884 887	p85
T18	Protein 932 943	IL-2R alpha
T19	Protein 1009 1012	p50
T20	Protein 1017 1020	p55
T21	Protein 1188 1191	p75
T22	Protein 1196 1199	p85
T23	Protein 1707 1722	glucose oxidase
T24	Protein 1744 1747	p75
T25	Protein 1752 1755	p85
T26	Protein 1783 1786	p50
T27	Protein 1791 1794	p55
